Want to see KR:185750 full AI Analyst Report?
Chong Kun Dang Pharmaceutical Corp. (185750) Income Statement
Chong Kun Dang Pharmaceutical Corp. Income Statement
Last quarter (Q2 2026), Chong Kun Dang Pharmaceutical Corp.'s total revenue was $478.47B, an increase of 10.03% from the same quarter last year. In Q2, Chong Kun Dang Pharmaceutical Corp.'s net income was $19.99B. See Chong Kun Dang Pharmaceutical Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.69T | $ 1.59T | $ 1.67T | $ 1.49T | $ 1.34T | |
| $ 517.23B | $ 532.61B | $ 662.20B | $ 542.64B | $ 495.82B | |
| $ 436.56B | $ 433.15B | $ 415.60B | $ 432.73B | $ 401.06B | |
| Depreciation and Amortization | $ 44.69B | $ 39.77B | $ 37.03B | $ 33.60B | $ 27.48B |
| $ 125.37B | $ 150.10B | $ 287.62B | $ 137.61B | $ 112.71B | |
| $ 80.57B | $ 99.46B | $ 246.60B | $ 109.91B | $ 94.76B | |
| $ 1.08B | $ 2.55B | $ -5.00B | $ -12.74B | $ -14.16B | |
| $ 81.65B | $ 102.01B | $ 241.60B | $ 97.17B | $ 80.59B | |
| $ 77.83B | $ 109.07B | $ 212.52B | $ 80.95B | $ 42.72B | |
| Per Share Metrics | |||||
| Basic EPS | $ 5882.09 | $ 8206.52 | $ 16704.00 | $ 6608.77 | $ 3117.59 |
| Diluted EPS | $ 5845.54 | $ 8206.52 | $ 16704.00 | $ 6608.77 | $ 3117.59 |
| Weighted Average Shares Outstanding | 13.18M | 13.25M | 12.72M | 12.25M | 12.44M |
| Weighted Average Shares Outstanding (Diluted) | 13.18M | 13.25M | 12.72M | 12.25M | 12.44M |
Currency in KRW
